These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31121591)

  • 1. Higher-Faster-Farther: Maximum Performance Tests in the Assessment of Neurogenic Speech Impairment.
    Ziegler W; Schölderle T; Brendel B; Amsellem J; Staiger A
    Folia Phoniatr Logop; 2019; 71(5-6):261-274. PubMed ID: 31121591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maximum performance tests in children with developmental spastic dysarthria.
    Wit J; Maassen B; Gabreëls FJ; Thoonen G
    J Speech Hear Res; 1993 Jun; 36(3):452-9. PubMed ID: 8331902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociating oral motor capabilities: Evidence from patients with movement disorders.
    Staiger A; Schölderle T; Brendel B; Ziegler W
    Neuropsychologia; 2017 Jan; 95():40-53. PubMed ID: 27939368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reference values of maximum performance tests of speech production.
    Knuijt S; Kalf J; Van Engelen B; Geurts A; de Swart B
    Int J Speech Lang Pathol; 2019 Feb; 21(1):56-64. PubMed ID: 28949263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construct-related validity of the TOCS measures: comparison of intelligibility and speaking rate scores in children with and without speech disorders.
    Hodge MM; Gotzke CL
    J Commun Disord; 2014; 51():51-63. PubMed ID: 25069811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traumatic versus perinatally acquired dysarthria: assessment by means of speech-like maximum performance tasks.
    Wit J; Maassen B; Gabreëls F; Thoonen G; de Swart B
    Dev Med Child Neurol; 1994 Mar; 36(3):221-9. PubMed ID: 8138071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Standardized Protocol for Maximum Repetition Rate Assessment in Children.
    Diepeveen S; van Haaften L; Terband H; de Swart B; Maassen B
    Folia Phoniatr Logop; 2019; 71(5-6):238-250. PubMed ID: 31256159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syllabic timing in dysarthria.
    Ziegler W; Hartmann E; Hoole P
    J Speech Hear Res; 1993 Aug; 36(4):683-93. PubMed ID: 8377481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards an automatic evaluation of the dysarthria level of patients with Parkinson's disease.
    Vásquez-Correa JC; Orozco-Arroyave JR; Bocklet T; Nöth E
    J Commun Disord; 2018; 76():21-36. PubMed ID: 30149241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated Speech Rate Measurement in Dysarthria.
    Martens H; Dekens T; Van Nuffelen G; Latacz L; Verhelst W; De Bodt M
    J Speech Lang Hear Res; 2015 Jun; 58(3):698-712. PubMed ID: 25860856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A speaking task analysis of the dysarthria in cerebellar disease.
    Kent RD; Kent JF; Rosenbek JC; Vorperian HK; Weismer G
    Folia Phoniatr Logop; 1997; 49(2):63-82. PubMed ID: 9197089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gauging the Auditory Dimensions of Dysarthric Impairment: Reliability and Construct Validity of the Bogenhausen Dysarthria Scales (BoDyS).
    Ziegler W; Staiger A; Schölderle T; Vogel M
    J Speech Lang Hear Res; 2017 Jun; 60(6):1516-1534. PubMed ID: 28538944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "The caterpillar": a novel reading passage for assessment of motor speech disorders.
    Patel R; Connaghan K; Franco D; Edsall E; Forgit D; Olsen L; Ramage L; Tyler E; Russell S
    Am J Speech Lang Pathol; 2013 Feb; 22(1):1-9. PubMed ID: 22846881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of speech task on intelligibility in dysarthria: a case study of Parkinson's disease.
    Kempler D; Van Lancker D
    Brain Lang; 2002 Mar; 80(3):449-64. PubMed ID: 11896652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ataxic dysarthria.
    Kent RD; Kent JF; Duffy JR; Thomas JE; Weismer G; Stuntebeck S
    J Speech Lang Hear Res; 2000 Oct; 43(5):1275-89. PubMed ID: 11063247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separate and Combined Influence of Cognitive Impairment and Dysarthria on Functional Communication in Multiple Sclerosis.
    Feenaughty L; Tjaden K; Weinstock-Guttman B; Benedict RHB
    Am J Speech Lang Pathol; 2018 Aug; 27(3):1051-1065. PubMed ID: 30054632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prosodic variation across sampling tasks in normal and dysarthric speakers.
    Lowit-Leuschel A; Docherty GJ
    Logoped Phoniatr Vocol; 2001; 26(4):151-64. PubMed ID: 12071568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of intensive speech rate and intonation therapy on intelligibility in Parkinson's disease.
    Martens H; Van Nuffelen G; Dekens T; Hernández-Díaz Huici M; Kairuz Hernández-Díaz HA; De Letter M; De Bodt M
    J Commun Disord; 2015; 58():91-105. PubMed ID: 26519934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive-linguistic deficit and speech intelligibility in chronic progressive multiple sclerosis.
    Mackenzie C; Green J
    Int J Lang Commun Disord; 2009; 44(4):401-20. PubMed ID: 19294553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining the effects of multiple sclerosis on speech production: does phonetic structure matter?
    Rosen KM; Goozée JV; Murdoch BE
    J Commun Disord; 2008; 41(1):49-69. PubMed ID: 17509609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.